Experimental products would get independent panel review for insurance coverage under California bill.
This article was originally published in The Gray Sheet
Executive Summary
CALIFORNIA EXPERIMENTAL THERAPIES BILL PROVIDES FOR INDEPENDENT REVIEW of health plan decisions to deny coverage in cases where the patient is terminally ill. The legislation, AB 1663, received final approval by the California Assembly with Senate concurrence on amendments Aug. 31, clearing the proposal for review by Gov. Pete Wilson (R). Wilson is expected to sign the measure the week of Sept. 9.